These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19038696)

  • 1. Binge alcohol treatment of adolescent rats followed by alcohol abstinence is associated with site-specific differences in bone loss and incomplete recovery of bone mass and strength.
    Lauing K; Himes R; Rachwalski M; Strotman P; Callaci JJ
    Alcohol; 2008 Dec; 42(8):649-56. PubMed ID: 19038696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of binge alcohol exposure on bone resorption and biomechanical and structural properties are offset by concurrent bisphosphonate treatment.
    Callaci JJ; Juknelis D; Patwardhan A; Sartori M; Frost N; Wezeman FH
    Alcohol Clin Exp Res; 2004 Jan; 28(1):182-91. PubMed ID: 14745317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term modulations in the vertebral transcriptome of adolescent-stage rats exposed to binge alcohol.
    Callaci JJ; Himes R; Lauing K; Roper P
    Alcohol Alcohol; 2010; 45(4):332-46. PubMed ID: 20554695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binge alcohol treatment increases vertebral bone loss following ovariectomy: compensation by intermittent parathyroid hormone.
    Callaci JJ; Juknelis D; Patwardhan A; Wezeman FH
    Alcohol Clin Exp Res; 2006 Apr; 30(4):665-72. PubMed ID: 16573585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D and ibandronate prevent cancellous bone loss associated with binge alcohol treatment in male rats.
    Wezeman FH; Juknelis D; Himes R; Callaci JJ
    Bone; 2007 Oct; 41(4):639-45. PubMed ID: 17643361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic alcohol consumption during male rat adolescence impairs skeletal development through effects on osteoblast gene expression, bone mineral density, and bone strength.
    Wezeman FH; Emanuele MA; Emanuele NV; Moskal SF; Woods M; Suri M; Steiner J; LaPaglia N
    Alcohol Clin Exp Res; 1999 Sep; 23(9):1534-42. PubMed ID: 10512321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spine bone mineral density and vertebral body height are altered by alcohol consumption in growing male and female rats.
    Wezeman FH; Juknelis D; Frost N; Callaci JJ
    Alcohol; 2003; 31(1-2):87-92. PubMed ID: 14615015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binge alcohol-induced bone damage is accompanied by differential expression of bone remodeling-related genes in rat vertebral bone.
    Callaci JJ; Himes R; Lauing K; Wezeman FH; Brownson K
    Calcif Tissue Int; 2009 Jun; 84(6):474-84. PubMed ID: 19330277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alendronate administration and skeletal response during chronic alcohol intake in the adolescent male rat.
    Wezeman FH; Emanuele MA; Moskal SF; Steiner J; Lapaglia N
    J Bone Miner Res; 2000 Oct; 15(10):2033-41. PubMed ID: 11028458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rat osteoporotic spine model for the evaluation of bioresorbable bone cements.
    Wang ML; Massie J; Perry A; Garfin SR; Kim CW
    Spine J; 2007; 7(4):466-74. PubMed ID: 17630145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel bone-specific molecular targets of binge alcohol and ibandronate by transcriptome analysis.
    Himes R; Wezeman FH; Callaci JJ
    Alcohol Clin Exp Res; 2008 Jul; 32(7):1167-80. PubMed ID: 18537941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binge drinking and bone metabolism in a young actively growing rat model.
    Sampson HW; Gallager S; Lange J; Chondra W; Hogan HA
    Alcohol Clin Exp Res; 1999 Jul; 23(7):1228-31. PubMed ID: 10443990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactinomas in adolescents: persistent bone loss after 2 years of prolactin normalization.
    Colao A; Di Somma C; Loche S; Di Sarno A; Klain M; Pivonello R; Pietrosante M; Salvatore M; Lombardi G
    Clin Endocrinol (Oxf); 2000 Mar; 52(3):319-27. PubMed ID: 10718830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-level lifetime exposure to cadmium decreases skeletal mineralization and enhances bone loss in aged rats.
    Brzóska MM; Moniuszko-Jakoniuk J
    Bone; 2004 Nov; 35(5):1180-91. PubMed ID: 15542044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraperitoneal injection of ethanol results in drastic changes in bone metabolism not observed when ethanol is administered by oral gavage.
    Iwaniec UT; Turner RT
    Alcohol Clin Exp Res; 2013 Aug; 37(8):1271-7. PubMed ID: 23550821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinal cord injury causes more damage to bone mass, bone structure, biomechanical properties and bone metabolism than sciatic neurectomy in young rats.
    Jiang SD; Jiang LS; Dai LY
    Osteoporos Int; 2006 Oct; 17(10):1552-61. PubMed ID: 16874443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lasofoxifene (CP-336,156) protects against the age-related changes in bone mass, bone strength, and total serum cholesterol in intact aged male rats.
    Ke HZ; Qi H; Chidsey-Frink KL; Crawford DT; Thompson DD
    J Bone Miner Res; 2001 Apr; 16(4):765-73. PubMed ID: 11316005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of low-dose parathyroid hormone on bone mass, turnover, and ectopic osteoinduction in a rat model for chronic alcohol abuse.
    Iwaniec UT; Trevisiol CH; Maddalozzo GF; Rosen CJ; Turner RT
    Bone; 2008 Apr; 42(4):695-701. PubMed ID: 18295560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minodronic acid ameliorates vertebral bone strength by increasing bone mineral density in 9-month treatment of ovariectomized cynomolgus monkeys.
    Tanaka M; Mori H; Kawabata K; Mashiba T
    Bone; 2016 Jul; 88():157-164. PubMed ID: 27155564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sclerostin Antibody Reverses Bone Loss by Increasing Bone Formation and Decreasing Bone Resorption in a Rat Model of Male Osteoporosis.
    Li X; Ominsky MS; Villasenor KS; Niu QT; Asuncion FJ; Xia X; Grisanti M; Wronski TJ; Simonet WS; Ke HZ
    Endocrinology; 2018 Jan; 159(1):260-271. PubMed ID: 29069393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.